Hematologic Malignancy
Primary Cutaneous Mature B-Cell Neoplasm
CI-CAN-00003737Explore in graph →
HematologicNon-malignant8 active trials
- NCIt
- C206305
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00003737Explore in graph →
Clinical trials
65 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06834373 | Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy | recruiting | Phase 2 | 41 | Mayo ClinicOTHER | 1 | Jan 28, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Jan 28, 2026source: clinicaltrials